Dr. Schlumbrecht on the Challenges of Diagnosing Uterine Leiomyosarcoma

Video

In Partnership With:

Matthew P. Schlumbrecht, MD, discusses ongoing challenges in diagnosing uterine leiomyosarcoma.

Matthew P. Schlumbrecht, MD, associate professor and co-director of Cancer Prevention and Control, Division of Gynecologic Oncology, Sylvester Comprehensive Cancer Center, University of Miami Health System, discusses ongoing challenges in diagnosing uterine leiomyosarcoma.

Not uncommonly, uterine leiomyosarcoma can be mistaken as a benign gynecologic condition such as fibroids, says Schlumbrecht. In many cases, women are diagnosed with uterine leiomyosarcoma after having undergone a hysterectomy for presumed fibroids, says Schlumbrecht.

For women who are diagnosed with uterine leiomyosarcoma, data suggest that ovarian preservation may be more beneficial than performing an oophorectomy, explains Schlumbrecht.

Little progress has been made in this space, says Schlumbrecht. Understanding how the molecular landscape changes over the disease course, as well as identifying potential therapeutic targets and predictive biomarkers may spark advancement in this field.

Related Videos
Shivaani Kummar, MBBS, FACP, Margaret and Lester DeArmond Endowed Chair of Cancer Research, Professor and Division Head, Division of Hematology/Medical Oncology, Oregon Health & Science University School of Medicine; co-director, Center for Experimental Therapeutics, co-deputy director, Knight Cancer Institute
Andre Goy, MD
Wenxin (Vincent) Xu, MD,
Guenther Koehne, MD, PhD
Alessandro Villa, DDS, PhD, MPH
Joseph Mikhael, MD
Michael Richardson, MD
Minesh Mehta, MD
Ruben Olivares, MD
Phillip J. Koo, MD